[
  {
    "objectID": "publications/publications.html",
    "href": "publications/publications.html",
    "title": "Publications",
    "section": "",
    "text": "Publication\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbstract/Poster"
  },
  {
    "objectID": "publications/publications.html#section",
    "href": "publications/publications.html#section",
    "title": "Publications",
    "section": "2024",
    "text": "2024\n\n\n\n\n\n\nA model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy\n\n\n\n\n\nJournal: CPT: Pharmacometrics & Systems Pharmacology\nPublication Date: 2024-10-03\nDOI: 10.1002/psp4.13246\nAuthors: Kim J, Morales JF, Kang S, Klose M, Willcocks RJ, Daniels MJ, Belfiore-Oshan R, Walter GA, Rooney WD, Vandenborne K, Kim S.\n\n\n\n\n\n\n\n\n\nType 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool\n\n\n\n\n\nJournal: CPT: Pharmacometrics & Systems Pharmacology\nPublication Date: 2024-07-03\nDOI: 10.1002/psp4.13193\nAuthors: Morales JF, Klose M, Hoffert Y, Podichetty JT, Burton J, Schmidt S, Romero K, O’Doherty I, Martin F, Campbell-Thompson M, Haller MJ, Atkinson MA, Kim S.\n\n\n\n\n\n\n\n\n\nPopulation pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial\n\n\n\n\n\nJournal: Cancer Chemother Pharmacol\nPublication Date: 2024-09\nDOI: 10.1007/s00280-024-04679-z\nAuthors: Mc Laughlin AM, Hess D, Michelet R, Colombo I, Haefliger S, Bastian S, Rabaglio M, Schwitter M, Fischer S, Eckhardt K, Hayoz S, Kopp C, Klose M, Sessa C, Stathis A, Halbherr S, Huisinga W, Joerger M, Kloft C.\n\n\n\n\n\n\n\n\n\nTLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)\n\n\n\n\n\nJournal: European Journal of Cancer\nPublication Date: 2024-04\nDOI: 10.1016/j.ejca.2024.113588\nAuthors: Colombo I, Koster KL, Holer L, Haefliger S, Rabaglio M, Bastian S, Schwitter M, Eckhardt K, Hayoz S, Mc Laughlin AM, Kloft C, Klose M, Halbherr S, Baumgartner C, Sessa C, Stathis A, Hess D, Joerger M.\n\n\n\n\n\n\n\n\n\nExploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation\n\n\n\n\n\nJournal: Eur J Pharm Sci\nPublication Date: 2024-03-01\nDOI: 10.1016/j.ejps.2023.106689\nAuthors: Klose M, Cristofoletti R, Silva CM, Mangal N, Turgeon J, Michaud V, Lesko LJ, Schmidt S."
  },
  {
    "objectID": "publications/publications.html#section-1",
    "href": "publications/publications.html#section-1",
    "title": "Publications",
    "section": "2022",
    "text": "2022\n\n\n\n\n\n\nThe Impact of UGT2B7 and CYP2D6 Gene-Drug- and CYP-mediated Drug-Drug-Interactions on Oxycodone and Oxymorphone Pharmacokinetics using PBPK Modelling.\n\n\n\n\n\nEvent: ACoP13 (2022)\nPublication Date: 2022\nLink: www.go-acop.org/?abstract=413\nAuthors: Klose M, Schmidt S, Cristofoletti R."
  },
  {
    "objectID": "publications/publications.html#section-2",
    "href": "publications/publications.html#section-2",
    "title": "Publications",
    "section": "2021",
    "text": "2021\n\n\n\n\n\n\nEvaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients\n\n\n\n\n\nJournal: Antibiotics (Basel)\nPublication Date: 2021-04-20\nDOI: 10.3390/antibiotics10040468\nAuthors: Liebchen U, Klose M, Paal M, Vogeser M, Zoller M, Schroeder I, Schmitt L, Huisinga W, Michelet R, Zander J, Scharf C, Weinelt FA, Kloft C.\n\n\n\n\n\n\n\n\n\nUsing microdose-based activity measurement to individualise dosing of cytochrome P450 metabolised drugs: a case study with yohimbine and tamoxifen.\n\n\n\n\n\nEvent: PAGE (2021) Publication Date: 2021\nLink: https://www.page-meeting.org/default.asp?abstract=9807\nAuthors: Michelet R, Weinelt FA, Klose M, Mc Laughlin AM, Kluwe F, Montefusco-Pereira C, Van Dyk M, Vay M, Huisinga W, Kloft C, Mikus G."
  },
  {
    "objectID": "publications/publications.html#section-3",
    "href": "publications/publications.html#section-3",
    "title": "Publications",
    "section": "2021",
    "text": "2021\n\n\n\n\n\n\nUsing microdose-based activity measurement to individualise dosing of cytochrome P450 metabolised drugs: a case study with yohimbine and tamoxifen.\n\n\n\n\n\nEvent: PAGE (2021) Publication Date: 2021\nLink: https://www.page-meeting.org/default.asp?abstract=9807\nAuthors: Michelet R, Weinelt FA, Klose M, Mc Laughlin AM, Kluwe F, Montefusco-Pereira C, Van Dyk M, Vay M, Huisinga W, Kloft C, Mikus G."
  },
  {
    "objectID": "posts/2024-01-30/index.html",
    "href": "posts/2024-01-30/index.html",
    "title": "xxx",
    "section": "",
    "text": "Lorem Ipsum"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Marian Klose",
    "section": "",
    "text": "I’m currently a PhD student at Freie Universitaet Berlin and member of the graduate research training program PharMetrX. I am supervised by Prof. Charlotte Kloft (Freie Universitaet Berlin) and co-supervised by Prof. Wilhelm Huisinga (University of Potsdam). My research focuses on how pharmacometric tools used within so-called model-informed precision dosing frameworks can be further optimised. Currently this means to investigate how full Bayesian approaches can be applied to our domain of pharmacometrics."
  },
  {
    "objectID": "index.html#about-me",
    "href": "index.html#about-me",
    "title": "Marian Klose",
    "section": "",
    "text": "I’m currently a PhD student at Freie Universitaet Berlin and member of the graduate research training program PharMetrX. I am supervised by Prof. Charlotte Kloft (Freie Universitaet Berlin) and co-supervised by Prof. Wilhelm Huisinga (University of Potsdam). My research focuses on how pharmacometric tools used within so-called model-informed precision dosing frameworks can be further optimised. Currently this means to investigate how full Bayesian approaches can be applied to our domain of pharmacometrics."
  },
  {
    "objectID": "posts.html",
    "href": "posts.html",
    "title": "Neuigkeiten",
    "section": "",
    "text": "xxx\n\n\n\ntest\n\n\ntest2\n\n\n\nxxx\n\n\n\nMarian Klose\n\n\nJan 24, 2024\n\n\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "publications/publications.html#a-model-informed-clinical-trial-simulation-tool-with-a-graphical-user-interface-for-duchenne-muscular-dystrophy",
    "href": "publications/publications.html#a-model-informed-clinical-trial-simulation-tool-with-a-graphical-user-interface-for-duchenne-muscular-dystrophy",
    "title": "Publications",
    "section": "A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy",
    "text": "A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy\nJournal: CPT: Pharmacometrics & Systems Pharmacology\nPublication Date: 2024-10-03\nDOI: 10.1002/psp4.13246\nAuthors: Jongjin Kim, Juan Francisco Morales, Sanghoon Kang, Marian Klose, Rebecca J. Willcocks, Michael J. Daniels, Ramona Belfiore-Oshan, Glenn A. Walter, William D. Rooney, Krista Vandenborne, et al."
  },
  {
    "objectID": "publications/publications.html#legend",
    "href": "publications/publications.html#legend",
    "title": "Publications",
    "section": "",
    "text": "Publication\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbstract/Poster"
  }
]